NET PROFIT (x1000 EUR)
EMPLOYEES
Cell Biotech International A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
356
|
324
|
255 |
Total assets |
3,797
|
3,317
|
2,653 |
Current assets |
3,035
|
2,548
|
1,899 |
Current liabilities |
1,845
|
1,701
|
1,318 |
Equity capital |
1,952
|
1,600
|
1,276 |
- share capital |
2,526
|
2,532
![]() |
2,532 |
Employees (average) |
7
![]() |
7
![]() |
7 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
51.4%
|
48.2%
|
48.1% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
164.5%
|
149.8%
|
144.1% |
Return on equity (ROE) |
18.2%
|
20.2%
|
20.0% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.